GENE ONLINE|News &
Opinion
Blog

Gene Therapy
Revealing the Underestimated Potential of Natural RNA Editing – An Interview with Dr. Trees-Juen Chuang
2021-09-17
AbbVie Strikes Gene Therapy Pact with REGENXBIO to Tackle Eye Diseases
2021-09-14
Harnessing Viral Evolution to Deliver Gene Therapy to Specific Tissues
2021-09-13
Cancer Fears Puts BioMarin’s Phearless Study on Hold
2021-09-07
Serious Adverse Event in Study Participant Marks Latest Roadblock for Astellas’ Gene Therapy Trial
2021-09-03
Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal
2021-08-25
Vertex Inks $1.2B Pact with Feng Zhang Cofounded Startup to Develop Gene Therapies for Blood Diseases
2021-08-25
Scientists Develop Drug Inducible Switch to Regulate Gene Therapy
2021-08-18
After FDA Lifts Hold, Novartis to Proceed with Clinical Trials for Expensive Rare Disease Therapy
2021-08-04
BIO Asia 2021 Highlights: Realizing The Promise of Cell and Gene Therapies
2021-08-02
New Gene Therapy Offers Hope to Reverse Rare Genetic Disorder in Children
2021-07-16
Novartis’ Expensive Gene Therapy for SMA Reasserts its Efficacy in Two Clinical Trials
2021-06-24
Setting its Sights on Neurological Disorders, CRISPR Therapeutics Turns to an AAV Startup That Just Emerged Out of Stealth
2021-06-16
Biogen Inks $120 Million Pact with High Flying Ginkgo Bioworks to Redefine Manufacturing of Gene Therapy Vectors
2021-05-23
Sarepta to Begin Phase 3 Rivalry with Pfizer after its DMD Gene Therapy Registers Encouraging Data
2021-05-21
1 3 4 5 6 7 9
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top